Ionis Pharmaceuticals, Inc. (IONS) Social Stream
IONIS PHARMACEUTICALS INC (IONS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IONS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 13 | $68 | $20 | $46.045 | $33.76 | 36.39% |
| 2021-12-07 | 13 | $68 | $20 | $45.409 | $33.76 | 34.51% |
| 2021-12-08 | 13 | $68 | $22 | $45.318 | $33.76 | 34.24% |
| 2021-12-28 | 13 | $68 | $22 | $45.136 | $33.76 | 33.7% |
| 2022-01-21 | 13 | $68 | $22 | $44.681 | $33.76 | 32.35% |
| 2022-02-24 | 13 | $68 | $22 | $43.772 | $33.76 | 29.66% |
| 2022-02-28 | 13 | $68 | $22 | $43.136 | $33.76 | 27.77% |
| 2022-03-01 | 15 | $68 | $22 | $42.125 | $33.76 | 24.78% |
| 2022-03-07 | 14 | $68 | $22 | $42.125 | $33.76 | 24.78% |
| 2022-03-24 | 13 | $68 | $22 | $41.708 | $33.76 | 23.54% |
| 2022-03-31 | 14 | $68 | $22 | $42.653 | $33.76 | 26.34% |
| 2022-04-13 | 14 | $68 | $22 | $42.423 | $33.76 | 25.66% |
| 2022-05-04 | 14 | $68 | $22 | $42.115 | $33.76 | 24.75% |
| 2022-06-13 | 13 | $68 | $22 | $42.666 | $33.76 | 26.38% |
| 2022-08-03 | 13 | $68 | $22 | $42.916 | $33.76 | 27.12% |
| 2022-08-04 | 13 | $68 | $22 | $43.333 | $33.76 | 28.36% |
| 2022-08-10 | 14 | $68 | $22 | $44.923 | $33.76 | 33.07% |
| 2022-08-13 | 14 | $68 | $22 | $46 | $33.76 | 36.26% |
| 2022-08-16 | 14 | $64 | $22 | $44.083 | $33.76 | 30.58% |
| 2022-10-14 | 13 | $64 | $22 | $46.333 | $33.76 | 37.24% |
| 2022-10-24 | 13 | $64 | $22 | $47 | $33.76 | 39.22% |
| 2022-11-04 | 12 | $64 | $22 | $45.818 | $33.76 | 35.72% |
| 2022-11-13 | 13 | $64 | $24 | $46.09 | $33.76 | 36.52% |
| 2022-11-30 | 13 | $64 | $24 | $46.636 | $33.76 | 38.14% |
| 2023-01-03 | 13 | $64 | $24 | $45.181 | $33.76 | 33.83% |
| 2023-01-06 | 13 | $64 | $24 | $45.727 | $33.76 | 35.45% |
| 2023-01-26 | 13 | $64 | $24 | $45.909 | $33.76 | 35.99% |
| 2023-02-08 | 13 | $64 | $24 | $46 | $33.76 | 36.26% |
| 2023-02-23 | 16 | $67 | $24 | $47.428 | $33.76 | 40.49% |
The Trend in the Analyst Price Target
Over the past 24 months, IONS's average price target has gone down $19.32.
IONS reports an average of 11.14% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-14 | 13 | 64 | 22 | 46.333 | 46.36 | -0.06% |
| 2022-12-21 | 13 | 64 | 24 | 45.181 | 38.82 | 16.39% |
| 2023-01-05 | 13 | 64 | 24 | 45.727 | 40.12 | 13.98% |
| 2023-02-03 | 13 | 64 | 24 | 46.000 | 40.92 | 12.41% |
| 2023-02-08 | 13 | 64 | 24 | 46.000 | 39.32 | 16.99% |
IONS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.38 | 6 | 2 | 5 | 1 | 1 | 16 |
The Trend in the Broker Recommendations
Over the past 52 weeks, IONS's average broker recommendation rating improved by 0.19.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IONS as an investment opportunity.
- In the context of all US stocks, IONIS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -3279.5% of them.
- IONS has a greater number of analysts covering the stock than 3370.37% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, IONIS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 781.42% of them.
- IONIS PHARMACEUTICALS INC's average analyst price target is greater than 987.1% of stocks in the large market cap category.
In the Pharmaceutical Products industry, SRPT, REGN, and BMY are the three stocks most similar to IONIS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding IONS using the data that counts. Try POWR Ratings for free.